IMB is a global leader in multidisciplinary life sciences research, bringing together 500 researchers from across the globe for disease discovery, application and sustainable futures. Formed in 2000 as an initiative of The University of Queensland, State and Federal Governments and private philanthropy, IMB is one of the largest life sciences institutes in the Asia-Pacific region. It has capitalised on one of the greatest periods of discovery in history – the genetic and molecular basis of life and its diversity.

Our research is framed through six research centres focusing on superbug infection, pain, heart disease, inflammation, solar biotechnology and the interplay of genomics and disease. We also undertake research in cancer, brain injury and disease, the environment and agricultural solutions.  Institute scientists use a range of model systems and facilities to advance their research in chemistry and structural biology, genomics of development and disease, and in cell biology and molecular medicine. IMB’s combination of life, pharmacological and chemical researchers means that the Institute can take life science discoveries from genome to drug design and application – for health, disease and for the sustainability of our cities, fuels and foods.